Orchid Pharma Limited

Web: orchidpharma.com NSE: ORCHPHARMA BSE: 524372 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

966 35(-4%)

Volume

2L as on 23, Jun

Open

1,727

High

1,814

Low

1,720

1,001

VWAP

987

52 Week High

1,120

52 Week Low

480

Viand Research Rating

Quality Score

33/100

Growth Score

11/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,899

No. of Shares

5.07

P/E

69.62

P/B

6.77

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.72

ROCE

Profit Growth

Listing Date

02-Nov-20

Promoter Holding

69.84%

FII Holding

0.87%

DII Holding

20.24%

Price Chart

Price Performance

1 Week6%

1 Month40%

3 Months94%

6 Months94%

1 Year94%

YTD94%

Moving Average

5 Day SMA994

10 Day SMA960

20 Day SMA885

30 Day SMA827

50 Day SMA737

61 Day SMA698

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,035	971	1,016	1,033
Resistance 2	1,016	967	998	1,015
Resistance 1	987	962	987	986
Pivot Point	969	958	969	968
Support 1	940	954	950	938
Support 2	921	949	939	920
Support 3	892	945	921	891

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(-2.61) 69.84%	(0.01) 72.40%	(-17.61) 72.40%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 90.00%	(0.01) 90.00%	(0.01) 90.00%
FIIs	(-0.31) 0.87%	(-0.41) 1.17%	(0.21) 1.56%	(-1.31) 1.39%	(0.21) 2.69%	(0.61) 2.53%	(0.51) 1.94%	(-0.51) 1.42%	(-2.21) 1.96%	(-3.91) 4.14%	(-0.51) 8.08%	(7.81) 8.58%	(0.01) 0.81%	(-0.51) 0.86%	(-0.11) 1.37%	(-0.11) 1.48%	(-0.21) 1.61%	(0.01) 1.78%	(0.01) 1.79%
DIIs	(0.91) 20.24%	(0.31) 19.38%	(-0.41) 19.04%	(-0.71) 19.43%	(1.11) 20.10%	(0.71) 19.00%	(-0.61) 18.30%	(1.21) 18.93%	(3.21) 17.73%	(2.11) 14.51%	(-1.01) 12.46%	(10.91) 13.48%	(-1.31) 2.62%	(1.01) 3.94%	(0.01) 2.98%	(0.01) 2.97%	(-0.41) 2.97%	(0.01) 3.35%	(0.01) 3.35%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.04%	0.04%
Public	9.04%	9.61%	9.57%	9.34%	7.37%	8.63%	9.94%	9.82%	10.47%	11.52%	7.05%	5.54%	6.60%	5.22%	5.69%	5.55%	5.39%	4.84%	4.83%
No. of Shareholders	35,118	35,709	38,155	39,827	34,303	34,158	36,363	34,695	36,720	36,931	29,197	29,132	29,523	30,894	32,717	33,679	33,698	33,533	34,798

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	238	207	194	173	237	217	223	244	217	221	199	183	210	160	165.25	131	178	161	128	92
Sales Growth % (YoY)	0%	-4.6%	-13.1%	-29.2%	9.4%	-1.5%	12%	33.6%	3.4%	38.1%	20.3%	39.6%	17.8%	-1%	29.4%	41.9%	49%	57%	17.7%	-22.5%
Sales Growth % (QoQ)	15%	6.7%	12.1%	-27%	9.2%	-2.7%	-8.6%	12.4%	-1.8%	11.1%	8.7%	-12.9%	31.2%	-3.2%	26.1%	-26.4%	10.6%	25.8%	39.1%	-
Expenses	211	206	195	159	209	191	192	212	188	185	175	161	170	146	147.43	119	152	147	116	95
Operating Profit	27	2	-1	14	28	26	30	32	29	35	23	22	40	14	17.82	12	26	14	11	-3
OPM %	11	1	-1	8	12	12	14	13	13	16	12	12	19	9	10.78	10	14	9	9	-3
Other Income	8	-2	11	11	4	8	8	8	13	8	8	2	34	9	5.84	3	0	-1	68	3
Interest	3	3	4	3	4	4	3	4	3	4	4	6	7	8	9.22	8	4	7	10	11
Depreciation	9	9	9	9	9	9	9	8	8	9	8	8	7	8	17.76	22	27	20	20	20
Profit before tax	23	-12	-3	14	19	22	26	28	30	30	20	11	59	7	-3.32	-14	-5	-14	49	-31
Tax %	0	0	0	0	0	0	0	-1	-10	0	0	0	0	0	0	0	0	0	0	0
Net Profit	24	-13	-6	15	22	21	27	29	33	29	20	9	59	8	-5.39	-15	-7	-14	49	-31
Net Profit Growth % (QoQ)	284.6%	-116.7%	-140%	-31.8%	4.8%	-22.2%	-6.9%	-12.1%	13.8%	45%	122.2%	-84.7%	637.5%	248.4%	64.1%	-114.3%	50%	-128.6%	258.1%	-
Net Profit Growth % (YoY)	9.1%	-161.9%	-122.2%	-48.3%	-33.3%	-27.6%	35%	222.2%	-44.1%	262.5%	471.1%	160%	942.9%	157.1%	-111%	51.6%	-	-	-	-
TTM Net Profit	20	18	52	85	99	110	118	111	91	117	96	70.61	46.61	-19.39	-41.39	13	-3	4	18	0
EPS in Rs	4.69	-2.49	-1.13	2.94	4.39	4.1	5.37	5.79	6.5	5.8	3.9	1.85	14.49	1.86	-1.32	-3.68	-1.61	-3.4	12.1	-7.57

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012	Jan 1900
Sales	811	922	819	666	560	450	484	600	683	797	873	1747	1948	1874	1747
Sales Growth %	-12%	12.5%	23%	19%	24.3%	-7%	-19.4%	-12.2%	-14.2%	-8.8%	-50%	-10.3%	4%	5.2%	-
Expenses	770	804	708	581	505	421	515	612	659	794	703	1429	1837	1517	1429
Operating Profit	41	118	111	84	55	29	-31	-12	24	3	171	317	110	357	317
OPM %	5	13	14	13	10	7	-6	-2	4	0	20	18	6	19	18
Other Income	29	27	31	52	67	15	24	218	20	-59	-28	156	92	52	156
Interest	13	15	17	33	33	52	6	7	310	347	294	537	523	180	537
Depreciation	35	35	33	55	87	109	118	130	133	141	145	325	252	154	325
Profit before tax	21	96	92	48	2	-117	-131	69	-399	-544	-296	-389	-573	75	-389
Tax %	-1	0	-3	0	0	0	0	0	-12	-9	-6	-49	-2	-29	-49
Net Profit	21	100	92	46	-2	-117	-131	69	-353	-495	-279	-197	-560	97	-197
Net Profit Growth %	-79%	8.7%	100%	2400%	98.3%	10.7%	-289.9%	119.5%	28.7%	-77.4%	-41.6%	64.8%	-677.3%	149.2%	-
EPS in Rs	4.05	19.65	18.17	11.35	-0.48	-28.55	-32.11	7.8	-39.65	-55.69	-31.37	-23.06	-79.21	13.84	-23.06
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	22	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012
Cash from Operating Activity	19	126	18	92	24	81	12	9	401	212	-369	168	737
Cash from Investing Activity	-27	-312	-31	113	67	167	45	-28	-176	-1	1334	-986	-293
Cash from Financing Activity	25	167	31	-217	-165	-250	0	33	-465	-286	-597	664	-480
Net Cash Flow	18	-19	18	-11	-74	-2	57	15	-240	-76	367	-153	-36

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012
Equity Capital	51	51	51	51	51	41	41	41	41	89	89	89	89	85	70	70
Reserves	1237	1223	1217	1174	1119	648	607	612	725	-793	-881	-556	-40	244	310	1062
Borrowings	363	282	175	165	135	331	268	453	566	3230	3202	3106	3215	3211	3204	2005
Other Liabilities	261	167	246	246	249	205	195	132	128	551	715	616	598	521	1067	801
Total Liabilities	1911	1722	1688	1635	1554	1225	1111	1237	1460	3077	3125	3256	3862	4061	4651	3938
Fixed Assets	692	631	633	650	620	573	584	670	858	1256	1386	1497	1637	1795	2584	2074
CWIP	341	120	81	25	31	46	10	7	26	278	272	288	280	282	360	352
Investments	53	49	50	48	46	44	45	15	0	0	1	1	1	1	1	1
Other Assets	826	922	925	912	857	561	472	544	576	1542	1467	1470	1944	1984	1706	1511
Total Assets	1911	1722	1688	1635	1554	1225	1111	1237	1460	3077	3125	3256	3862	4061	4651	3938

Delivery

#	Date	690 62% 1120	Value (Cr)	Q/T 17	Del 34	Del 17
1	22-Jul	1001	10	10	44	4
2	21-Jul	1023	8	8	39	3
3	20-Jul	1047	6	9	28	2
4	17-Jul	1041	13	11	40	5
5	16-Jul	1079	16	14	38	6
6	15-Jul	1101	35	13	30	11
7	14-Jul	1053	83	15	13	11
8	13-Jul	1007	16	14	34	5
9	10-Jul	1013	29	13	32	9
10	9-Jul	1051	77	17	30	23
11	8-Jul	1002	330	26	10	32
12	7-Jul	925	5	10	52	2
13	6-Jul	934	4	13	51	2
14	3-Jul	956	6	14	46	3
15	2-Jul	979	6	14	38	2
16	1-Jul	975	4	13	40	1
17	30-Jun	973	7	16	35	2
18	29-Jun	951	11	20	48	5
19	25-Jun	963	5	16	48	2
20	24-Jun	994	11	12	39	4
21	23-Jun	990	18	16	39	7
22	22-Jun	958	8	17	51	4
23	19-Jun	979	11	11	38	4
24	18-Jun	1008	8	10	37	3
25	17-Jun	1037	28	11	28	8
26	16-Jun	1048	79	14	18	14
27	15-Jun	961	24	15	44	10
28	12-Jun	917	45	21	28	13
29	11-Jun	846	14	14	39	6
30	10-Jun	851	4	17	57	2
31	9-Jun	860	3	17	43	1
32	8-Jun	843	19	21	36	7
33	5-Jun	844	4	19	55	2
34	4-Jun	835	9	19	44	4
35	3-Jun	837	21	25	34	7
36	2-Jun	825	9	16	46	4
37	1-Jun	777	7	13	28	2
38	29-May	792	23	20	34	8
39	27-May	761	11	17	44	5
40	26-May	724	9	20	30	3
41	25-May	715	6	20	52	3
42	22-May	706	5	17	42	2
43	21-May	708	2	15	51	1
44	20-May	715	3	14	48	2
45	19-May	736	6	15	49	3
46	18-May	713	2	7	55	1
47	15-May	713	4	19	59	2
48	14-May	719	6	13	55	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	4,900c	193c	3.78
22-Jul	5,092c	101c	1.95
21-Jul	5,194c	76c	1.44
17-Jul	5,270c	195c	3.57
16-Jul	5,465c	52c	0.94
15-Jul	5,517c	188c	3.54
14-Jul	5,328c	191c	3.71
13-Jul	5,138c	74c	1.43
10-Jul	5,212c	114c	2.13
09-Jul	5,326c	228c	4.48
08-Jul	5,097c	404c	8.61
07-Jul	4,693c	54c	1.14
06-Jul	4,747c	317c	6.25
02-Jul	5,064c	119c	2.41
01-Jul	4,945c	26c	0.52
30-Jun	4,920c	203c	4.30
29-Jun	4,717c	158c	3.23
26-Jun	4,874c	16c	0.33
25-Jun	4,890c	130c	2.59
24-Jun	5,020c	52c	1.03
23-Jun	5,072c	233c	4.82
22-Jun	4,839c	82c	1.67
19-Jun	4,921c	182c	3.56
18-Jun	5,102c	152c	2.90
17-Jun	5,255c	46c	0.88
16-Jun	5,209c	300c	6.11
15-Jun	4,909c	238c	5.09
12-Jun	4,671c	410c	9.62
11-Jun	4,261c	77c	1.77
10-Jun	4,338c	0	0

Stock Checklist

Price is above from 52 week high low average: 52%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 57 fund scheme(s) across 11 fund house(s) as of Jul26 · Total value ₹1,355 Cr · 17 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Kotak Mahindra Mutual Fund	16	1.09%	+0.43%	454.4
quant Mutual Fund	2	0.71%	-	433.8
UTI Mutual Fund	8	0.74%	-	228.2
Invesco Mutual Fund	5	0.29%	+0.16%	120.3
Bandhan Mutual Fund	14	16.35%	-	95.2
Tata Mutual Fund	2	0.66%	-	18
WhiteOak Capital Mutual Fund	2	0.27%	+0.04%	3.5
PGIM India Mutual Fund	2	0.70%	-	1.3
Angel One Mutual Fund	2	0.00%	-	0
Mirae Asset Mutual Fund	2	0.00%	-	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Orchid Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements